Pay in 4 interest-free payments of $5.24 Learn more
Ships within 48 hours · Estimated delivery Jul 31 - Aug 5
Table of Contents Product Category Diabetes GLP-1 Receptor Agonist Generic Name or Biosimilar No Active Ingredient Liraglutide Prescription Status Prescription-only Targeted Conditions Victoza is approved to treat: Type 2 Diabetes Mellitus (T2DM), as an adjunct to diet and exercise Cardiovascular risk reduction in adults with T2DM and established cardiovascular disease Off-Label Usage While not formally approved, Victoza has also been prescribed off-label for: Weight loss in individuals with obesity or overweight (in lower doses than Saxenda, which contains the same ingredient at higher doses) Polycystic Ovary Syndrome (PCOS) with metabolic dysfunction Nonalcoholic fatty liver disease (NAFLD) or steatohepatitis (NASH) All off-label use must be supervised by a licensed healthcare provider
Resistance exercise minimizes this muscle loss, preserving metabolic rate and ensuring that weight lost comes primarily from fat stores rather than lean tissue
Emerging Trends and Challenges Comparative performance landscape (across the 100 studies)
Schedule your appointment with Skin Glow Dermatology Today
Weight loss injections work best when combined with a personalized diet and exercise plan
